HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment Of Crohn's Disease

... Abbott announced today it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA(R) (adalimumab) as a treatment for reducing the signs and symptoms and inducing and maintaining clinical remission in adults with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy. [click link for full article] ...